Edition:
United States

ConvaTec Group PLC (CTEC.L)

CTEC.L on London Stock Exchange

135.15GBp
11:44am EDT
Change (% chg)

2.30 (+1.73%)
Prev Close
132.85
Open
132.90
Day's High
135.65
Day's Low
132.80
Volume
4,017,033
Avg. Vol
5,161,866
52-wk High
240.50
52-wk Low
113.25

Latest Key Developments (Source: Significant Developments)

Convatec Group Appoints Genus Plc's Karim Bitar As CEO
Monday, 25 Mar 2019 03:01am EDT 

March 25 (Reuters) - ConvaTec Group PLC ::CONVATEC GROUP PLC - APPOINTS KARIM BITAR AS CHIEF EXECUTIVE OFFICER.  Full Article

Genus Plc Says CEO Stepping Down, To Take Top Job At Convatec
Monday, 25 Mar 2019 03:01am EDT 

March 25 (Reuters) - Genus PLC ::GENUS - GENUS CHIEF EXECUTIVE TRANSITION.GENUS PLC - KARIM BITAR, CHIEF EXECUTIVE OFFICER, WILL BE STEPPING DOWN FROM BOARD FROM 16 SEPTEMBER 2019.GENUS PLC - COMMENCED A SEARCH TO IDENTIFY BITAR'S SUCCESSOR.GENUS PLC - BITAR WILL BE TAKING CHIEF EXECUTIVE OFFICER POSITION AT CONVATEC GROUP PLC FROM 30 SEPTEMBER 2019.  Full Article

Convatec Will Appoint New CEO, Announce Exit Of Chris Gent As Chairman - Sky News
Sunday, 24 Mar 2019 04:54pm EDT 

March 24 (Reuters) - :CONVATEC WILL APPOINT A NEW CEO AND ANNOUNCE EXIT OF CITY VETERAN CHRIS GENT AS CHAIRMAN - SKY NEWS.CONVATEC WILL SAY THAT KARIM BITAR, CURRENTLY CHIEF EXECUTIVE OF GENUS‎, WILL JOIN IT IN AS CEO - SKY NEWS.  Full Article

ConvaTec Receives FDA 510(K) Clearance For Avelle
Friday, 26 Oct 2018 05:22am EDT 

Oct 26 (Reuters) - ConvaTec Group PLC ::CONVATEC RECEIVES FDA 510(K) CLEARANCE FOR AVELLE.AVELLE NPWT SYSTEM CAN BE USED ON A BROAD RANGE OF LOW- TO MODERATELY-EXUDING WOUND TYPES.  Full Article

Artisan Partners Limited Partnership Discloses 5.03 Pct Stake In Convatec Group - Filing
Thursday, 13 Sep 2018 05:00am EDT 

Sept 13 (Reuters) - ConvaTec Group PLC ::ARTISAN PARTNERS LIMITED PARTNERSHIP DISCLOSES 5.03 PERCENT STAKE IN CONVATEC GROUP - FILING.  Full Article

Convatec Says Acquired J&R Medical LLC
Friday, 2 Mar 2018 02:00am EST 

March 2 (Reuters) - Convatec Group Plc ::‍CHANGES WITHIN U.S. HOME DISTRIBUTION GROUP​.‍ANNOUNCES ACQUISITION OF J&R MEDICAL LLC​.‍CONVATEC HAS DIVESTED ITS RESPIRATORY DELIVERY BUSINESS IN ARIZONA AND UTAH​.‍NET FINANCIAL IMPACT TO CONVATEC OF DEAL AND DIVESTMENT TRANSACTIONS IS POSITIVE IN BOTH REVENUE AND EBITDA​.  Full Article

Convatec Sees FY 2018 Organic Revenue Growth Of 2.5% - 3.0%
Thursday, 15 Feb 2018 02:00am EST 

Feb 15 (Reuters) - Convatec Group Plc ::FY ‍GROUP REPORTED REVENUE OF $1,764.6 MILLION GREW 4.5% YEAR ON YEAR, 4.1% 3 CER OR 2.3% 4 ORGANICALLY VERSUS. REVISED GUIDANCE OF 1% TO 2% ORGANIC REVENUE GROWTH​.FY ‍ADJUSTED GROSS MARGIN INCREASED 10 BPS, INCLUDING 80 BPS FOREIGN EXCHANGE BENEFIT​.FY ‍UNDERLYING 70 BPS DECLINE, IN-LINE WITH REVISED GUIDANCE​.FY ‍REPORTED OPERATING PROFIT $247.8 MILLION, 60.9% INCREASE YEAR ON YEAR​.FY ‍ADJUSTED OPERATING PROFIT $456.8 MILLION, 3.3% LOWER YEAR ON YEAR DUE TO INCREASED INVESTMENT IN GROWTH AND INCLUSION OF PLC COSTS​.FY ‍SUPPLY CONSTRAINTS PREVIOUSLY REPORTED IN ADVANCED WOUND CARE AND OSTOMY CARE NOW RESOLVED​.‍FULL YEAR DIVIDEND 5.7 CENTS​.‍SEES 2018 ORGANIC REVENUE GROWTH OF 2.5% - 3.0%​.‍SEES DECLINE IN EBIT MARGIN IN 2018 DUE TO DECISION TO INCREASE TARGETED INVESTMENT, DESPITE TEMPORARY SHORTFALL IN REVENUE GROWTH​.  Full Article

Convatec reports Q3 revenue of $445.5 mln, up 6.8 pct
Monday, 16 Oct 2017 02:00am EDT 

Oct 16 (Reuters) - Convatec Group Plc ::IN Q3, GROUP REVENUE WAS $445.5 MILLION, REFLECTING 6.8 PCT REPORTED GROWTH ON SAME PERIOD IN 2016​.PERFORMANCE IN Q3 SEVERELY IMPACTED BY SUPPLY ISSUES IN BOTH ADVANCED WOUND AND OSTOMY CARE.‍GROUP NOW ANTICIPATE FULL YEAR ORGANIC REVENUE GROWTH WILL BE BETWEEN 1% AND 2%​.‍SUPPLY ISSUES ARE EXPECTED TO RESULT IN LOSS OF 40 BPS OF MARGIN BENEFIT ACHIEVED AS A RESULT OF MIP PROGRAMME IN FIRST HALF OF YEAR​.  Full Article

Convatec says CFO Nigel Clerkin to leave​
Thursday, 3 Aug 2017 02:15am EDT 

Aug 3 (Reuters) - CONVATEC GROUP PLC ::‍NIGEL CLERKIN, CURRENT CFO, HAS DECIDED NOT TO RELOCATE HIS FAMILY FROM DUBLIN AND CONSEQUENTLY WILL LEAVE COMPANY​.‍EXPECTED THAT CLERKIN WILL CONTINUE IN HIS POSITION AS A DIRECTOR OF COMPANY AND CFO UNTIL 31 OCTOBER 2017​.‍APPOINTMENT OF FRANK SCHULKES AS CFO DESIGNATE, EFFECTIVE TODAY, BECOMING CFO ON 31 OCTOBER 2017​.  Full Article

CONVATEC confirms guidance for the full year
Thursday, 3 Aug 2017 02:15am EDT 

Aug 3 (Reuters) - CONVATEC GROUP PLC ::HY GROUP REPORTED REVENUE OF $831.3 MILLION GREW 0.3%.MARGIN IMPROVEMENT PROGRAMME ON TRACK FOR FULL YEAR GUIDANCE - 40 BASIS POINTS (BPS) PERFORMANCE BENEFIT IN H1.INAUGURAL INTERIM DIVIDEND OF 1.4 CENTS PER SHARE.GUIDANCE FOR FULL YEAR IS CONFIRMED, REVENUE GROWTH WEIGHTED TOWARDS SECOND HALF OF YEAR.CONTINUE TO EXPECT TO DELIVER AROUND HALF OF TARGETED C. 300 BPS ADJUSTED GROSS MARGIN IMPROVEMENT DURING 2017.CONTINUE TO EXPECT STRONGER REVENUE GROWTH IN SECOND HALF DRIVEN BY FOAM, SILVER, SURGICAL COVER DRESSINGS.  Full Article

UPDATE 2-European stocks claw back up after four-day drop

March 26 European shares rose on Tuesday, snapping a four-day losing streak, boosted by healthcare stocks and on indications that UK Prime Minister Theresa May's deal to exit the European Union could gain some support.